When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
Norman J KachuckUniversity of Southern California, Keck School of Medicine, Los Angeles, CA, USAAbstract: New more powerful therapies for the treatment of multiple sclerosis may also confer a potential for unprecedented life-endangering side effects. How does a physician respond to a patient&...
Main Author: | Kachuck NJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-04-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/when-neurologist-and-patient-disagree-on-reasonable-risk-new-challenge-a7145 |
Similar Items
-
Use of monoclonal antibodies in patients with multiple sclerosis in the practice of a neurologist
by: N. Yu. Lashch
Published: (2020-03-01) -
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
by: Lidia Del Piccolo, et al.
Published: (2015-01-01) -
When Great Scholars Disagree
by: Alan Sica
Published: (2014-05-01) -
Utility of Lorenz Curves in Examining Physician Prescribing Practices: Example of Ontario Neurologist Prescribing of Multiple Sclerosis Disease-modifying Therapies in 2009
by: Marriott, James John
Published: (2012) -
Utility of Lorenz Curves in Examining Physician Prescribing Practices: Example of Ontario Neurologist Prescribing of Multiple Sclerosis Disease-modifying Therapies in 2009
by: Marriott, James John
Published: (2012)